2.71 USD
▼-0.03-1.09%
盘后 2.71 -0.04%
2026-09-15
市值
$523.40M
市盈率
—
EPS
-0.28
股息率
—
52 周区间
1.12 – 3.11
成交量
988.53K
Beta
0.25
目标价
5.80
52W 低 1.1252W 高 3.11
价格走势
公司简介
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's d...